BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8315081)

  • 1. Propylthiouracil in psoriasis: results of an open trial.
    Elias AN; Goodman MM; Liem WH; Barr RJ
    J Am Acad Dermatol; 1993 Jul; 29(1):78-81. PubMed ID: 8315081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of topical propylthiouracil in the treatment of patients with psoriasis.
    Elias AN; Dangaran K; Barr RJ; Rohan MK; Goodman MM
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):455-8. PubMed ID: 8077472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis.
    Köse K; Utaş S; Yazici C; Akdaş A; Keleştimur F
    Br J Dermatol; 2001 Jun; 144(6):1121-6. PubMed ID: 11422030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral propylthiouracil for the treatment of resistant plaque psoriasis.
    Chowdhury MM; Marks R
    J Dermatolog Treat; 2001 Jun; 12(2):81-5. PubMed ID: 12243663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy and safety of propylthiouracil in psoriasis: an open-label study.
    Gnanaraj P; Malligarjunan H; Dayalan H; Karthikeyan S; Narasimhan M
    Indian J Dermatol Venereol Leprol; 2011; 77(6):673-6. PubMed ID: 22016273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of involucrin in psoriatic lesions following therapy with propylthiouracil, an anti-thyroid thioureylene: immunohistochemistry and gene expression analysis.
    Gnanaraj P; Dayalan H; Elango T; Malligarjunan H; Raghavan V; Rao R
    Int J Dermatol; 2015 Mar; 54(3):302-6. PubMed ID: 25267471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PTU on IL-12 and IL-10 in psoriasis.
    Elias AN; Nanda VS; Barr RJ
    J Drugs Dermatol; 2003 Dec; 2(6):645-8. PubMed ID: 14711144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p16 expression in psoriatic lesions following therapy with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Barr RJ; Nanda VS
    Int J Dermatol; 2004 Dec; 43(12):889-92. PubMed ID: 15569009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1a expression in psoriatic skin following treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Barr RJ
    BMC Dermatol; 2003 Jul; 3():3. PubMed ID: 12841851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant potential of propylthiouracil in patients with psoriasis.
    Utaş S; Köse K; Yazici C; Akdaş A; Keleştimur F
    Clin Biochem; 2002 May; 35(3):241-6. PubMed ID: 12074833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of orally administered antithyroid thioureylenes on PCNA and P53 expression in psoriatic lesions.
    Elias AN; Barr RJ; Rohan MK; Dangaran K
    Int J Dermatol; 1995 Apr; 34(4):280-3. PubMed ID: 7790147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients.
    Malligarjunan H; Gnanaraj P; Subramanian S; Elango T; Dayalan H
    Clin Biochem; 2011 Oct; 44(14-15):1209-13. PubMed ID: 21820424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of propylthiouracil on quality of life in psoriasis patients.
    Malligarjunan H; Dayalan H; Gnanaraj P; Elango T; Subramanian S
    Indian J Med Sci; 2011 Aug; 65(8):331-6. PubMed ID: 23442529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of propylthiouracil and methimazole on serum levels of interleukin-2 receptors in patients with psoriasis.
    Elias AN; Goodman MM; Rohan MK
    Int J Dermatol; 1993 Jul; 32(7):537-40. PubMed ID: 8340196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum TNF-alpha in psoriasis after treatment with propylthiouracil, an antithyroid thioureylene.
    Elias AN; Nanda VS; Pandian R
    BMC Dermatol; 2004 Apr; 4():4. PubMed ID: 15119959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose oral propylthiouracil in the treatment of plaque psoriasis.
    Elias AR; Barr RJ
    Int J Dermatol; 1995 Jul; 34(7):519-20. PubMed ID: 7591425
    [No Abstract]   [Full Text] [Related]  

  • 18. Thyroid hormones in alcoholic liver disease. Effect of treatment with 6-n-propylthiouracil.
    Israel Y; Walfish PG; Orrego H; Blake J; Kalant H
    Gastroenterology; 1979 Jan; 76(1):116-22. PubMed ID: 758132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating hormone in adult euthyroid and hypothyroid horses.
    Breuhaus BA
    J Vet Intern Med; 2002; 16(1):109-15. PubMed ID: 11822799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Propylthiouracil-induced overt hepatic injury in patients with hyperthyroidism].
    Lian XL; Bai Y; Dai WX; Guo ZS; Li W; Lu L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):172-7. PubMed ID: 15171556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.